China Biopharmaceuticals' Gross Profit Increases 102% China Biopharmaceuticals' Gross Profit Increases 102%

China Biopharmaceuticals' Gross Profit Increases 102‪%‬

Biotech Financial Reports 2008, Jan 1, 15, 1

Biotech Financial Reports
    • $5.99
    • $5.99

Publisher Description

China Biopharmaceuticals Holdings, Inc. (BULLETIN BOARD: CHBP) , a leading Chinese pharmaceutical company focused on the development, manufacturing and marketing of innovative drugs in China, has announced its results for the third quarter ended September 30, 2007. Revenue for the three months ended September 30, 2007 increased 65% to $8.6 million compared to $5.2 million for the period ended September 30, 2006. The increase in revenues was attributable to the revenue growth of the company's subsidiary Eyre Pharmaceutical Limited Company (''Erye''). Additionally, the company did not realize quarterly revenue from Shenyang Enshi Pharmaceutical Limited Company (''Enshi''), as this subsidiary was returned to RimAsia Capital Partners. Management believes that recent industry developments in China have provided Erye a great opportunity to continue to grow its core business going forward.

GENRE
Business & Personal Finance
RELEASED
2008
January 1
LANGUAGE
EN
English
LENGTH
7
Pages
PUBLISHER
Worldwide Videotex
SELLER
The Gale Group, Inc., a Delaware corporation and an affiliate of Cengage Learning, Inc.
SIZE
56.6
KB

More Books Like This

-Lockheed Martin Announces Third Quarter 2011 Results -Lockheed Martin Announces Third Quarter 2011 Results
-Lockheed Martin Announces Third Quarter 2011 Results
2011
Neovasc Inc. Reports Financial Results for the Second Quarter of 2010 Neovasc Inc. Reports Financial Results for the Second Quarter of 2010
Neovasc Inc. Reports Financial Results for the Second Quarter of 2010
2010
Delglobal has Fiscal 2008 3rd QTR Net Loss of $1.6 Mil (Financial Report) Delglobal has Fiscal 2008 3rd QTR Net Loss of $1.6 Mil (Financial Report)
Delglobal has Fiscal 2008 3rd QTR Net Loss of $1.6 Mil (Financial Report)
2008
Enzon Reports 2Nd Qtr 2010 Loss of $5.4 Million (Financial Report) Enzon Reports 2Nd Qtr 2010 Loss of $5.4 Million (Financial Report)
Enzon Reports 2Nd Qtr 2010 Loss of $5.4 Million (Financial Report)
2010
CIBER Reports First Quarter 2010 Results; Company Delivers Revenue of $262.7 Million and GAAP EPS of $0.05 Per Diluted Share CIBER Reports First Quarter 2010 Results; Company Delivers Revenue of $262.7 Million and GAAP EPS of $0.05 Per Diluted Share
CIBER Reports First Quarter 2010 Results; Company Delivers Revenue of $262.7 Million and GAAP EPS of $0.05 Per Diluted Share
2010
Supergen has 2009 3RD Qtr Total Revenues of $10.4 Million (Financial Report) Supergen has 2009 3RD Qtr Total Revenues of $10.4 Million (Financial Report)
Supergen has 2009 3RD Qtr Total Revenues of $10.4 Million (Financial Report)
2009

More Books by Biotech Financial Reports

Ing Renault F1 Team Chooses Appro Xtreme-X Supercomputer Ing Renault F1 Team Chooses Appro Xtreme-X Supercomputer
Ing Renault F1 Team Chooses Appro Xtreme-X Supercomputer
2008
Avigen Reports Net Loss of $7.3 MIL for 2nd QTR 2008 (Financial Report) Avigen Reports Net Loss of $7.3 MIL for 2nd QTR 2008 (Financial Report)
Avigen Reports Net Loss of $7.3 MIL for 2nd QTR 2008 (Financial Report)
2008
Sangamo Reports Net Loss of $7.4 MIL for 2nd QTR 2008 (Financial Report) Sangamo Reports Net Loss of $7.4 MIL for 2nd QTR 2008 (Financial Report)
Sangamo Reports Net Loss of $7.4 MIL for 2nd QTR 2008 (Financial Report)
2008
Delglobal has Fiscal 2008 3rd QTR Net Loss of $1.6 Mil (Financial Report) Delglobal has Fiscal 2008 3rd QTR Net Loss of $1.6 Mil (Financial Report)
Delglobal has Fiscal 2008 3rd QTR Net Loss of $1.6 Mil (Financial Report)
2008
Gilead Sciences Reports 2nd QTR Revenues of $1.28 Billion (Financial Report) Gilead Sciences Reports 2nd QTR Revenues of $1.28 Billion (Financial Report)
Gilead Sciences Reports 2nd QTR Revenues of $1.28 Billion (Financial Report)
2008
Curis Reports First QTR 2008 Net Loss of $3.4 Million (Financial Report) Curis Reports First QTR 2008 Net Loss of $3.4 Million (Financial Report)
Curis Reports First QTR 2008 Net Loss of $3.4 Million (Financial Report)
2008